Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

by Allegretti, J.R, Baniecki, M.L, Chandra, D.E, Danese, S., Hassan-Zahraee, M., Hung, K.E, Hyde, C.L, Karlsson, F., Klopocka, M., Lepsy, C., Li, X., Longman, R., Neelakantan, S., Quan, J., Raha, N., Romatowski, J., Scherl, E.J, Schoenbeck, U., Vincent, M.S, Xi, L., Ye, Z., Zhang, J., Ziemek, D.
Published 2022